Other (please specify with Rights Statement) General rights Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes permitted by law.
INTRODUCTION
Most people suffer from musculoskeletal pain at least once in their lifetime [1] . As such, musculoskeletal pain is a highly prevalent and costly condition [1] . It is the second most common cause of disability in the general population [2] . There are many established factors (physical, biological, cognitive, behavioural, social, occupational) associated with poor prognosis following the onset of musculoskeletal pain [1, 3] which helps to explain why many people do not recover after an episode of acute musculoskeletal pain often resulting in a downward spiral of negative physical, social, and psychological consequences [4] . Among the many biopsychosocial factors which contribute to the experience and impact of pain, negative or maladaptive psychological factors (e.g., fear) are amongst the most important [5] [6] [7] [8] .
Fear is considered to be a relevant factor in order to understand how acute pain becomes chronic for some people, and why pain and associated outcomes (e.g. disability) persist once the tissue damage has healed [9, 10] . In this sense, the fear-avoidance (FA) model of pain is one of the frameworks which has received more empirical attention in order to explain the development and persistence of disability following an acute episode of musculoskeletal pain [9, 11] . According to this model, individuals with a trait tendency to have fear and catastrophic thoughts in response to pain are more at risk of developing chronic musculoskeletal pain (CMP) after an injury compared to individuals who do not have this tendency [9] . These individuals overreact in response to actual or potential threats, developing avoidance behaviours (e.g. hypervigilance) which aim to prevent a new injury/re-injury [9] . Fear in relation to pain has been described with a variety of conceptual definitions among which pain-related fear, fear-avoidance beliefs, fear of movement, and kinesiophobia are the most commonly used [12] . 6 Physical inactivity is a potential factor for developing and maintaining CMP [13] .
Whereas physical activity has positive benefits in decreasing pain and disability in some CMP conditions, e.g., lower limb osteoarthritis [14] . However, people with CMP often show fear of movement [15, 16] , which limits the adequate execution of a movement or exercise and leads to more sedentary behaviour [17] . Such fear imposes a barrier when exercise is prescribed as part of management resulting in significant clinical implications including reduced adherence to treatment and perseverance of a negative experience with pain [11] .
Kinesiophobia (also known as fear of movement) is defined as an excessive, irrational, and debilitating fear to carry out a physical movement, due to a feeling of vulnerability to a painful injury or re-injury [18] . Both constructs are very similar [12] , and essentially they have the same clinical relevance. Whilst kinesiophobia is usually assessed with the Tampa Scale of Kinesiophobia (TSK), there is not a specific tool to assess fear of movement [12] . The prevalence of kinesiophobia in persistent pain ranges from 50 to 70% [19, 20] . It can be acquired through two forms: a direct aversive experience (e.g. pain or trauma) or social learning (observation and instruction) [21] .
Kinesiophobia may be associated with pain and associated outcomes (disability and quality of life) in several ways. First, kinesiophobia alters how people move, possibly with the initial goal to avoid pain. It causes adjustments of motor behaviour which affects the performance of actions related to the management and control of pain and pain-related disability [22] . Second, the processing of pain and pain-related information in people with CMP could be related to how kinesiophobia is perceived [23] . Indeed, a greater degree of kinesiophobia predicts greater levels of pain [24] . 7 The role of kinesiophobia in CMP has been explored extensively. In this regard, a large body of evidence has reported that kinesiophobia is associated with disability [25], pain [26] [27] [28] , and quality of life [29] . Furthermore, longitudinal studies have shown that high levels of kinesiophobia at baseline, predict negative changes in quality of life [30] , and positive changes in disability [31] , and pain [30, 32] . However, the evidence is inconsistent regarding the strength of the significance and the direction of the findings [33] [34] [35] [36] [37] . A synthesis of the evidence of the association between kinesiophobia and pain, disability, and quality of life would contribute to a better understanding and clarification of these relationships in patients with CMP. Moreover, examining the prognostic value of kinesiophobia on the aforementioned outcomes would facilitate a greater understanding of CMP mechanisms, and, thus permit better clinical decision-making.
Clinical decision-making requires ongoing reconciliation of studies that provide different answers to the same question, and clinicians and researchers can also benefit from a summary where uncertainty remains [38] .
A systematic review of the literature will allow stronger conclusions to be reached compared to those achieved by any one study [39] , and will facilitate readers who may have difficulties to capture and review all the evidence provided by primary studies.
Hence, the aim of this systematic review was twofold: (i) to explore the level of association between kinesiophobia and pain, disability, and quality of life in people with CMP; (ii) to analyse the prognostic value of kinesiophobia on pain, disability, and quality of life in people with CMP.
METHODS
This review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement [40] . The systematic 8 review protocol was registered at the International Prospective Register of Systematic Reviews (PROSPERO: CRD 42016042641). The initial intent of the study, as registered in PROSPERO, was to examine predictive studies only. This approach was abandoned since too few predictive studies existed and we determined that cross-sectional studies and case-control studies were also relevant to include in order to provide additional information on the level of association between kinesiophobia and outcomes related to CMP.
Data Sources and Search Strategy
The following electronic databases from the inception to February 2017 were searched:
PubMed, AMED, CINAHL, PsycINFO, and PubPsych. An update of the search strategy was carried out in July 2017 to identify if any new potential studies had been published.
A manual search of relevant eligible studies was also carried out. A sensitive search strategy using relevant search terms that were developed from Medical Subject Headings (MeSH), and keywords generated from the subject headings, were used (Appendix A). The following grey literature databases were explored: JBI COnNECT +, NHS Evidence, New York Academy of Medicine Grey Literature Report, Explore the British Library, TRIP database, National Guideline Clearinghouse, and Open Grey.
Eligibility Criteria
The PECOS (P-patient; E-exposure; C-comparator; O-outcome; S-study design) framework was followed to determine which studies to include in the present systematic review. Each study had to meet the following inclusion criteria:
(i) Observational studies (cross-sectional, case-control and longitudinal studies) exploring the predictive role of kinesiophobia in people with CMP, and their associations with the outcomes described below. When prospective studies only 9 reported findings from the baseline assessment in sufficient detail, analyses between kinesiophobia and outcome measures were limited to the initial assessment and considered as cross-sectional studies.
(ii) Studies whose participants were adults diagnosed with CMP, defined in this review as persistent or episodic pain lasting more than three months, around the axial skeleton (neck, low back, and/or pelvic) or peripheral joints (shoulder, elbow, wrist, knee, and/or ankle). In this regard, the ACCTION-APS Pain Taxonomy (AAPT) for chronic pain was used [41] , including people with diagnoses of chronic myofascial pain, fibromyalgia, chronic widespread pain (e.g. chronic fatigue syndrome), rheumatoid arthritis, spondyloarthropathies, and those with a diagnosis of osteoarthritis. Although the AAPT for chronic pain does not consider spinal pain as part of the musculoskeletal pain group, we decided to include people with chronic axial musculoskeletal pain in the present review.
(iii) Only studies measuring kinesiophobia with the Tampa Scale for Kinesiophobia (TSK) were included [12] . (vii) Studies were only included if there was at least one association between kinesiophobia and one of the following outcome measures: pain, disability and/or quality of life. With regards to the pain construct, the authors of the present review recognise that the differences between pain intensity and pain severity are narrow.
However, in order to facilitate the synthesis of results, we divided both constructs based on a previous literature review [42] which showed that pain intensity is commonly measured with unidimensional instruments (e.g., the numerical rating scale (NRS)), whereas pain severity is mostly measured with multidimensional instruments (e.g., the multidimensional pain inventory (MPI)), where not only intensity of pain is taken into account.
Exclusion criteria were as follows:
(i) Studies of acute pain, subacute pain, and chronic non-musculoskeletal pain according to the AAPT.
(ii) Studies where CMP was associated with a diagnosis of major psychiatric disorders.
(iii) studies evaluating kinesiophobia in CMP attributed to previous fracture or exploring this factor before surgery or post-surgery. (vii) Reviews, clinical studies, case reports, editorial, and abstracts.
Study Selection
First, two authors (JMC and ALS) carried out the screening of titles and abstracts.
Second, the same authors checked the full text of the included manuscripts. Third, in case of any disagreement, a decision was made by consensus with the participation of a third author (DF). A short checklist was adapted to the present review and was used to guide the selection of relevant studies (see Appendix B) [43] .
Data Extraction

11
The following relevant data from each study were extracted: study details (first author, year of publication), sample size, characteristics of participants (mean age, pain duration, pain condition), kinesiophobia measures, outcome (pain, disability, and quality of life) measures, duration of follow-up (in case of longitudinal studies), and study design. When necessary, an email was sent to the original authors to obtain further information regarding a study's findings.
Quality Assessment
The risk of bias of each included study was evaluated using an adapted version of the Newcastle-Ottawa Scale (NOS) [44] . This adapted version includes four domains of risk of bias assessment: methods for selecting study participants (selection bias), methods to control for confounding (performance bias), statistical methods (detection bias), and methods of exposure and outcome assessment (information bias). Seven items compose the four domains. Each item is scored from zero (high risk) to three (low risk) points. Therefore, the maximum score for each study could be twenty-one points. Two researchers (JMC and ALS) were involved at this stage. When any disagreement did appear, a third researcher (DF) was consulted and a decision by consensus was carried out. Qualitative analysis of the evidence was carried out involving a rating system (the Modified Cochrane Back and Neck group) with five levels of scientific evidence [45] .
The rating system was based on the methodological quality and the outcome of the studies: (i) strong evidence: consistent findings in two or more low risk of bias studies (score from 14 to 21 on NOS); (ii) moderate evidence: consistent findings in one low risk of bias study or two or more moderate risk of bias studies (score from 8 to 13 on NOS); (iii) limited evidence: consistent findings in one or more high risk of bias studies (score from 0 to 7 on NOS) or one moderate risk of bias study; (iv) lacking evidence: no published studies found; (v) conflicting evidence: inconsistent or contradictory findings within a quality level. Due to the absence of a cut-off in the adapted NOS scale, the authors decided to divide the scores in three sections (mentioned above) according to the levels of evidence included in the Modified Cochrane Back and Neck Group Criteria (low 0-7 on NOS; moderate 8-13 on NOS; strong 14-21 on NOS).
Statistical Analysis
For the primary analysis, studies were grouped per outcomes: disability, pain, and quality of life. A meta-analysis could not be carried out due to the presence of heterogeneity in terms of participant's age, sample size, pain condition, outcome measures, version of self-reported kinesiophobia questionnaire (e.g. TSK-11 or TSK-17), statistical methods used, and study design in most of the studies potentially eligible for conducting a meta-analysis. Consequently, a descriptive quantitative analysis (the most relevant summary measure with a precision estimate) was provided for each study.
For those studies that reported results with several degrees of adjustment for confounders in different models, we extracted the estimate from the model which showed the best adjustment.
Results
Study characteristics
A total of 1,757 articles were identified through electronic databases, with 148 additional studies identified through reference screening. Six hundred and forty-four satisfied our inclusion criteria and were included in this review. In case of longitudinal studies, duration of follow-up ranged from three to twelve months. Outcomes measures were as follows: disability [15,16,25- The characteristics of the included studies are reported in Appendix E. Eight authors were contacted directly by email to gather any non-published data.
Risk of bias
The degree to which studies met the risk of bias criteria varied considerably. The risk of bias assessment of all included studies is presented in Appendix F.
The role of kinesiophobia on pain intensity, pain severity, disability, and quality of life in CMP
After analysing the quality of evidence for each outcome included in the present systematic review through the Adapted Cochrane Back and Neck Pain Group Criteria, the evidence was divided between strong and moderate for cross-sectional studies (see Table 1 ) and limited to moderate for longitudinal studies (see Table 2 ). The statistical results for the association between kinesiophobia and pain, disability, and quality of life (cross-sectional analysis) are presented in Appendix G, and the predictive value of kinesiophobia on pain, disability, and quality of life (longitudinal analysis) are presented in Appendix H. 
The association between kinesiophobia and pain in people with CMP (cross-sectional analysis)
The association between kinesiophobia and pain intensity based on cross-sectional analyses was evaluated by thirty-eight studies. A total of twenty-one studies showed a significant association between a greater degree of kinesiophobia and greater levels of pain intensity [15, Altuğ et al.
[28] showed a non-significant association between kinesiophobia and pain intensity at rest, whereas this association was significant and positive during activity.
Lamoth et al.
[27] showed a non-significant association between kinesiophobia and anticipated pain, whereas this association was significant and positive with regards to actual pain. Lundberg et al.
[26] showed a significant and positive association between kinesiophobia and CLBP, although this association was non-significant when CLBP was diagnosed as non-specific CLBP. Overall the quality of the evidence was strong.
The association between kinesiophobia and pain severity based on cross-sectional analyses was evaluated in four studies. Two studies showed a significant association between a greater degree of kinesiophobia and greater of levels of pain severity [82, 92] .
There was no significant relationship between kinesiophobia and pain severity in one study [93] . One study showed inconsistency in the strength of the significance in their findings [15] . Bränström et al. [15] showed a non-significant association between kinesiophobia and pain severity in men, whereas this association was significant and positive in women. Overall the quality of the evidence was moderate.
The predictive value of kinesiophobia on pain in people with CMP (longitudinal analysis)
The predictive value of kinesiophobia on pain intensity in people with CMP was explored in two studies based on longitudinal analyses [31, 66] . Helminen et al. [31] reported that the degree of kinesiophobia at baseline did not predict changes in pain intensity at twelve months after adjusting for age, gender, educational level, comorbidities, body mass index, work status, marital status, and disease severity. Koho et al. [66] reported that kinesiophobia at baseline did not predict changes in pain intensity at twelve months but no covariates were reported. The overall quality of the evidence was conflicting.
The predictive value of kinesiophobia on pain severity in people with CMP was explored in two studies based on longitudinal analyses [30, 32] . Wong et al. [30] reported that baseline kinesiophobia significantly predicted positive changes in pain severity at six months, even when adjusted for sociodemographic factors, and pain variables (number, duration, and intensity). Van den Houte et al.
[32] did not report the predictive value of kinesiophobia on pain severity. The overall quality of the evidence was limited.
The association between kinesiophobia and disability in people with CMP (crosssectional analysis)
The association between kinesiophobia and disability was evaluated by forty-six studies based on cross-sectional analyses. A total of thirty studies showed a significant association between greater degree of kinesiophobia and greater levels of disability Bränström et al. [15] reported a significant and positive association between kinesiophobia and disability in women, whereas this association was non-significant in men. Heuts et al.
[61] found a significant and positive association between kinesiophobia and disability when kinesiophobia was measured with the somatic focus subscale of TSK but not with the activity-avoidance subscale for TSK. Lundberg et al.
[26] showed a significant and positive association between kinesiophobia and disability in CLBP, although this association was non-significant when CLBP was diagnosed as non-specific CLBP. De Moraes Vieira et al. [73] reported a significant and positive association between kinesiophobia and moderate-severe disability, whereas this association was non-significant when the level of disability was minimal. The overall quality of the evidence was strong.
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The predictive value of kinesiophobia on disability in people with CMP (longitudinal analysis)
The predictive value of kinesiophobia on disability in people with CMP was explored in seven studies based on longitudinal analyses [16,30- [31] , body mass index [31] , pain variables (number, duration, severity, and intensity) [16, 30] , disability at baseline [16] , work status [31] , marital status [31] , and disease severity [31] . One study [32] reported a significant and positive association between kinesiophobia at baseline and disability after the intervention at three months without adjusting for covariates. Furthermore, Lüning Bergsten et al. [70] found a significant and positive association between changes in kinesiophobia after intervention and changes in disability after intervention without adjusting for any covariates.
However, the relationship between changes in kinesiophobia at six months and changes in disability at six months was not reported. On the other hand, Matos et al. [71] reported that kinesiophobia at baseline did not predict changes in disability at three months. No covariates were reported. Koho et al. [66] also showed that kinesiophobia at baseline did not predict changes in disability at twelve months. No covariates were reported. The overall quality of the evidence was moderate.
The association between kinesiophobia and quality of life in people with CMP (crosssectional analysis)
The association between kinesiophobia and quality of life was evaluated in eight studies based on cross-sectional analyses. A total of three studies showed a significant association between a greater levels of kinesiophobia and lower levels of quality of life
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[29, 72, 80] . There was no significant relationship between kinesiophobia and quality of life in one study [96] . Finally, four studies showed inconsistency in the strength of the in their findings [28, 47, 89, 94] . Altuğ et al.
[28] found a significant and negative association between kinesiophobia and quality of life according to general health, physical function, social function, roles restricted by physical function and bodily pain.
However, this association was not significant according to the role restricted by mental function, vitality, and mental health. Askary-Ashtiani et al. [47] showed a significant and negative association between kinesiophobia and quality of life (physical function), although this association was not significant in relation to mental health. Larsson et al.
[97] reported a significant and negative association between kinesiophobia and quality of life when health is poor, whereas this association was not significant when health was very good, good, and fair. Nijs and Thielemans [94] showed a significant and negative association between kinesiophobia and quality of life according to the role limitations due to physical problems, mental health, and general health perception. However, this association was not significant according to physical functioning, role limitations due to emotional problems, social functioning, bodily pain, and vitality. The overall quality of the evidence was moderate.
The predictive value of kinesiophobia on quality of life in people with CMP (longitudinal analysis)
The predictive value of kinesiophobia on quality of life in people with CMP was explored in two studies based on longitudinal analyses [30, 95] . Wong et al. [30] reported that greater degree of kinesiophobia at baseline significantly predicted lower levels of quality of life at six months, even after being adjusted for sociodemographic factors, and pain variables (number, duration, and intensity). However, the relationship was only significant with respect to physical function. Orenius et al. [95] reported that 20 kinesiophobia at baseline did not predict changes in quality of life at twelve months. No covariates were reported. Moreover, the predictive value of changes in kinesiophobia at twelve months and changes in quality of life at twelve months was not reported. The overall quality of the evidence was limited.
DISCUSSION
The synthesis of the data from the included studies in this systematic review showed the following findings: For the cross-sectional analyses: (i) strong evidence of an association between a greater degree of kinesiophobia and greater levels of pain intensity and disability; (ii) moderate evidence for an association between a greater degree of kinesiophobia and greater levels of pain severity; (iii) moderate evidence for an association between greater levels of kinesiophobia and lower quality of life. For the longitudinal analyses: (i) a greater degree of kinesiophobia at baseline predicts the progression of disability overtime, with moderate evidence; (ii) a greater degree of kinesiophobia at baseline predicts greater levels of pain severity at a six month followup, with limited evidence; (iii) greater levels of kinesiophobia at baseline predict lower quality of life at six months, with limited evidence; (iv) conflicting evidence was found in support of kinesiophobia as a predictor of changes in pain intensity.
Comparison with other studies
This is the first synthesis of the evidence evaluating the role of kinesiophobia on pain, disability, and quality of life in people with CMP through the analysis of both crosssectional and longitudinal studies. Fear is a basic emotion, which appears as a reaction to a specific, identifiable, and imminent threat (e.g. a fall) [98] . It is constituted by three components: interpretation of the stimulus as threatening, increased sympathetic arousal, and defensive behaviour [99] . Escape behaviours are a defensive and adaptive response to stimulus (e.g., pain) in the short term (acute phase) [100] , and they can 21 reduce fear levels. However, in the long term (chronic phase), this avoidance activity can become maladaptive. People with CMP are presumed to develop kinesiophobia [15, 16] . They often avoid activities which are assumed to provoke a real or potential injury/re-injury, developing in turn, further physical inactivity [9] . This fear to carry out certain movements can cause a negative vicious cycle where people with CMP show greater levels of pain, disability and emotional distress [9] , and as a result, poor quality of life [101] . Our results support this statement as we identified moderate and strong evidence of associations between a greater degree of kinesiophobia and greater levels of pain, greater levels of disability and poorer quality of life, and in addition, moderate evidence that a greater degree of kinesiophobia is a predictor of the progression of disability overtime. Other systematic reviews have evaluated the role of other constructs of fear in acute, subacute, and chronic pain [102] [103] [104] [105] . Zale and Ditre [102] showed how pain-related fear is associated with more severe disability in different acute and chronic pain conditions. Wertli et al. explored the prognostic value of fear-avoidance in low back pain [104] , and also its role as a mediator of the treatment efficacy in this population [103] . Their findings showed that fear-avoidance predicted the delay of recovery in acute and subacute low back pain, favouring the development of chronicity [104] . Furthermore, fear avoidance also predicted poor treatment responses in acute, subacute and early chronic low back pain [103] . Finally, Kroska [105] reported how fear-avoidance is correlated with pain intensity bidirectionally in chronic pain conditions through the analysis of 118 cross-sectional studies.
Strengths and weaknesses of the study
The present systematic review has several strengths and some limitations that should be mentioned. The strengths are as follows: first, the elaboration and registration of a pre- constructs (e.g., fear avoidance beliefs or fear of pain), they are not necessarily interchangeable, and readers should consider this when interpreting the results. We selected those studies using the TSK to measure kinesiophobia. Although the TSK has been shown to be the most extended tool to assess this construct [12] , this may limit the interpretation of our results. We should also recognise several modifications from the initial protocol registered in PROSPERO (CRD 42016042641), as follows: (i) we decided to include cross-sectional and case-control studies, in order to provide information, not only on the prognostic value of kinesiophobia, but also on the level of 23 association between kinesiophobia and outcomes related to CMP; (ii) The Grading of Recommendations Assessment, Development and Evaluation (GRADE) and Risk of bias assessment of prognostic factor studies (QUIPS) were replaced by the adapted version of NOS and by the Modified Cochrane Back and Neck Pain Group Criteria. In our search strategy we used specific keywords related to pain, (e.g., chronic pain, low back pain), and did not use "pain" alone, so we may have missed useful studies.
Moreover, we did not include the keyword "hip pain" in our search strategy, so we may have missed relevant studies here too.
Clinical implications
Kinesiophobia is known to be a barrier to rehabilitation adherence in different chronic pain conditions [23, 107] . However, it is also considered to be a modifiable factor that may facilitate earlier achievement of pain relief and functional recovery [108] . In this sense, clinicians should need to identify the presence of kinesiophobia prior to the prescription of any intervention, e.g., exercise therapy, since its presence may require a different and more specific approach than standard rehabilitation programmes.
Furthermore, although rather speculative, individuals with CMP showing a greater degree of kinesiophobia could be more inclined to search for biomedical explanations and solutions for their pain disorder, due to fear for carrying out exercise or to understand their pain from a biopsychosocial perspective [23] , giving rise to more comorbid disorders [109] . In this context, kinesiophobia may cause frustration for both patients and therapists, negatively affecting their therapeutic relationship, and limiting rehabilitation efforts [109] . Therefore, ideally the presence of kinesiophobia should be detected during the first assessment, to plan biopsychosocial treatment strategies focused on the modification of kinesiophobia. This could be achieved through the 24 selection of functional goals, education to manage safe behaviours, and graded exposure to feared activities in the form of behavioural experiments (e.g. exposure in vivo) [9] .
Future Research
In 
CONCLUSIONS
This systematic review revealed that a greater degree of kinesiophobia is associated with greater levels of pain intensity, pain severity and disability, as well as lower quality of life, based on the analysis of cross-sectional studies. The analysis of the prognostic role of kinesiophobia showed that greater levels of kinesiophobia at baseline predict higher levels of disability, pain severity and lower quality of life at a six month followup, while kinesiophobia does not predict changes in pain intensity. The results of this systematic review encourage clinicians to evaluate kinesiophobia in patients with CMP,
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as the presence of kinesiophobia can impact on adherence to exercise therapy and may require specific management strategies such as the selection of functional goals, education to manage safe behaviours, and graded exposure to feared activities. Due to the low number of longitudinal studies found in this review, and the low level of the evidence attained in the analysis, causality was not firmly demonstrated, thus, further longitudinal studies are needed.
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